EDEKA Paschmann First German Retailer to Use Diebold Nixdorf’s AI-Powered Solution to Combat Shrink at Self-Checkout

Technology provides important assistance so customers can accurately and conveniently process transactions EDEKA Paschmann in Düsseldorf is the first supermarket in Germany to use Diebold Nixdorf's (NYSE: DBD) Vynamic® Smart Vision I Shrink Reduction solution at its self-service checkouts. The AI-enabled technology addresses errors at the self-service checkout – both unintentional and deliberate – and […]

Immunophotonics and Swiss Cancer Institute Complete SAKK 66/17 Phase 1b/2a Multicenter Clinical Trial for Treatment of Solid Tumors

Immunophotonics, Inc., a clinical-stage biotech company focused on developing novel immune-stimulating drugs to augment routine tumor destruction techniques, announced the completion of its multicenter clinical trial (SAKK 66/17) conducted in collaboration with the Swiss Cancer Institute (formerly known as SAKK). This milestone – along with completion of the Company's INJECTABL-1 trial covering different indications, which

60% of adopters of AI SOCs have cut investigation time by at least 25%

Gurucul's 2025 Pulse of the AI SOC report highlights real ROI for AI SOC automation Gurucul, the leader in data and security analytics, today announced the findings of its 2025 Pulse of the AI SOC research report, developed in partnership with Cybersecurity Insiders. Based on survey responses from 739 cybersecurity leaders worldwide, the report reveals

Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures

(TSX:SIA), NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) announced today that it has completed its previously announced offering (the “Offering“) of $175 million aggregate principal amount of series E

Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures

Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures GlobeNewswire August 21, 2025 NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company“) (TSX: SIA) announced today that it

Bayer’s E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program

LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) — AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural and food technology markets, today announced that Bayer has been selected as the recipient of “AI-based AgTech Solution of the Year” for E.L.Y. in the 5th annual AgTech

Bayer’s E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program

Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program Annual Awards Program Recognizes Innovation in Agricultural & Food Technologies Around the Globe GlobeNewswire August 21, 2025 LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) — AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products

Lumo Launches Pump Automation, Integrated with Block-Level Irrigation Data for Safety, Reliability and Optimal Pump-to-Plant Performance

Lumo, the leader in precision irrigation technology for specialty crop growers, today announced the launch of Pump Automation, a powerful new integration with its smart valve platform. https://mma.prnewswire.com/media/2754928/Lumo_field_employee_installs_pump_automation_at_Antinori_Napa_Valley_s_Antica_Ranch.jpg “Lumo's pump automation is an absolute game changer for our team!” -Hunter Emch, Redwood Empire Vineyard Management Select growers on the North and Central Coasts are already

Leqvio® advances toward broader access with agreement between Novartis and the pan-Canadian Pharmaceutical Alliance

— Eligible Canadian patients with heterozygous familial hypercholesterolemia (HeFH) are one step closer to publicly funded access to cholesterol lowering treatment. Novartis Pharmaceuticals Canada Inc. is pleased to announce the successful conclusion of negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of Leqvio® (inclisiran) for the treatment of adults with heterozygous familial

Scroll to Top